Yatharth Hospital acquires 60 per cent stake for Rs 152 crore in 400-bedded hospital in Faridabad

Published On 2024-11-03 09:15 GMT   |   Update On 2024-11-03 09:15 GMT

New Delhi: Yatharth Hospital and Trauma Care Services announced on Wednesday that its board has approved the acquisition of a 60 per cent stake in a Faridabad-based hospital services company MGS Infotech Research and Solutions, which is yet to begin operations, for an enterprise value of ₹152 crore. 

The target company is yet to commence a 400-bed hospital in Faridabad, Haryana.

Also Read:Yatharth Hospital receives order from MP Govt for takeover of Ramraja Hospital premises

The acquisition will strengthen the company's presence in Delhi-NCR, it said.

The structure of the Faridabad-based hospital is completed and expected to be operational in 6-10 months from the date of acquisition, it added.

On Wednesday, Yatharth Hospital announced that it has emerged as the successful bidder of a super speciality hospital located in Delhi.

The acquired hospital is a well-established hospital in Model Town, New Delhi, it had stated, news agency PTI reported.

The hospital has an expandable capacity of 300-plus beds and caters to a large catchment of residential and institutional client base.

Also Read:Yatharth Hospital & Trauma Care raises Rs 120 crore in pre-IPO round

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News